Area of research
Immunology · Renewable Energy, Sustainability and the Environment
Research interest
Research focused on Pharmacovigilance and DNA methylation, with related work in Adverse Event Reporting System, Lymph node, Percutaneous coronary intervention. Notable publications include 'Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system', 'Biparametric MRI of the prostate radiomics model for prediction of pelvic lymph node metastasis in prostate cancers : a two-centre study', and 'Impact of White Blood Cell Count After Percutaneous Coronary Intervention on Long-Term Prognosis in Patients with Unstable Angina Pectoris: A Single-Center Retrospective...'.
Impact of White Blood Cell Count After Percutaneous Coronary Intervention on Long-Term Prognosis in Patients with Unstable Angina Pectoris: A Single-Center Retrospective Observational Cohort Study
Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system
Biparametric MRI of the prostate radiomics model for prediction of pelvic lymph node metastasis in prostate cancers : a two-centre study
The Research Progress of DNA Methylation in the Development and Function of the Porcine Placenta